|
Market Closed -
NSE India S.E.
12:22:03 30/10/2026 GMT
|
5-day change | 1st Jan Change | ||
| 2,298.70 INR | -1.72% |
|
+6.10% | +12.95% |
| 10-29 | Glenmark Pharmaceuticals Inc. USA Inaugurates Allentown Distribution Center | CI |
| 09-11 | Glenmark Pharmaceuticals Limited Proposes Dividend for the Year Ended 31 March 2026 | CI |
Stock exchange
NSE India S.E.
GLENMARK 2,298.70 ₹
-1.72%
986M
₹
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
| GLENMARK | 2,298.70INR | -1.72% | 986M ₹ | ||
Bombay S.E.
| GLENMARK | 2,308.00INR | -1.07% | 11.58M ₹ |
Quotes 5-day view: Glenmark Pharmaceuticals Limited
Delayed Quote NSE India S.E.
| 26/10/2026 | 27/10/2026 | 28/10/2026 | 29/10/2026 | 30/10/2026 | |
|---|---|---|---|---|---|
| Last | ₹2,225.80 | ₹2,265.70 | ₹2,300.00 | ₹2,339.00 | ₹2,298.70 |
| Volume | 969,672 | 483,378 | 455,830 | 232,396 | 428,887 |
| Change | +2.73% | +1.79% | +1.51% | +1.70% | -1.72% |
| Opening | ₹2,135.60 | ₹2,214.70 | ₹2,268.00 | ₹2,311.00 | ₹2,336.00 |
| High | ₹2,229.00 | ₹2,275.00 | ₹2,318.00 | ₹2,339.00 | ₹2,337.30 |
| Low | ₹2,133.00 | ₹2,214.60 | ₹2,261.90 | ₹2,295.30 | ₹2,291.30 |
Performance
| 1 day | -1.72% | ||
| 1 week | +6.10% | ||
| Current month | -1.54% | ||
| 1 month | -1.54% | ||
| 3 months | +4.95% | ||
| 6 months | -4.47% | ||
| Current year | +12.95% | ||
| 1 year | +22.09% | ||
| 3 years | +206.43% | ||
| 5 years | +356.18% | ||
| 10 years | +145.85% |
Volumes
marketsDaily volume
428,887
Estimated daily volume
428,887
Avg. Volume 20 sessions
520,814
Daily volume ratio
0.82
Avg. Volume 20 sessions INR
1,197,195,141.8
Avg. Volume 20 sessions USD
12,608,859.23
Record volume 1
89,266,590
Record volume 2
65,123,680
Record volume 3
39,631,540
Capital turnover ratio
0
Float rotation
0
Basic data
Market Cap (INR)
648,694,999,644
Market Cap (USD)
6,831,913,821
Net sales (INR)
169,825,110,000
Net sales (USD)
1,788,560,906
Number of employees
16,946
Sales / Employee (INR)
10,021,545
Sales / Employee (USD)
105,545
Free-Float
51.04%
Free-Float capitalization (INR)
331,132,284,125
Free-Float capitalization (USD)
3,487,412,774
Average Daily Capital Traded
0.18%
Indicators
Moving average 5 days
2,285.84
Moving average 20 days
2,260.53
Moving average 50 days
2,354.56
Moving average 100 days
2,291.12
Price spread / (MMA5)
-0.56%
Price spread / (MMA20)
-1.66%
Price spread / (MMA50)
+2.43%
Price spread / (MMA100)
-0.33%
RSI 9 days
62.8
RSI 14 days
55.73
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.72% | +6.10% | +22.09% | +206.43% | 6.83B | |
| +3.19% | +11.31% | +67.86% | +150.58% | 1,263B | |
| -0.73% | +3.56% | +44.51% | +85.81% | 658B | |
| +1.41% | +3.24% | +29.22% | +107.83% | 521B | |
| +0.42% | +3.20% | +54.15% | +67.18% | 391B | |
| +2.18% | +2.93% | +73.30% | +45.62% | 369B | |
| +1.12% | +4.52% | +35.30% | +58.08% | 307B | |
| +6.96% | +8.86% | +11.27% | +36.62% | 290B | |
| +1.15% | +6.09% | +59.59% | +77.06% | 252B | |
| +3.06% | +9.38% | +44.11% | +119.47% | 212B | |
| Average | +1.38% | +5.92% | +44.14% | +95.47% | 426.88B | |
| Weighted average by Cap. | +1.19% | +6.60% | +50.83% | +98.49% |
Historical Quotes: Glenmark Pharmaceuticals Limited
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Latest transactions
512aa7eac36b95862d09.E9Fs4b2-aQs5Ma990-3fh3urK7D-GMQC94iTUKOtv3w.ZOAaj_nOKzhMQ-k-44Gu6TLKQt-4eYhTm-vDPNmZ2xN5iFWV1uslT2Ne2A
| Date | Price | Volume | Total |
|---|---|---|---|
| 10:27:43 | 2,298.70 | 1 | 409,169 |
| 10:20:50 | 2,298.70 | 106 | 409,168 |
| 10:20:07 | 2,298.70 | 1 | 409,062 |
| 09:45:00 | 2,310.00 | 40 | 409,061 |
| 09:44:54 | 2,317.90 | 53 | 409,021 |
| 09:44:47 | 2,305.10 | 204 | 408,968 |
| 09:44:40 | 2,317.00 | 403 | 408,764 |
| 09:44:33 | 2,313.60 | 620 | 408,361 |
| 09:44:27 | 2,318.70 | 884 | 407,741 |
Price Extremes
| 1 week | 2,133 |  | 2,339 |
| 1 month | 2,101.6 | | 2,340.5 |
| Current year | 1,842 | | 2,537.6 |
| 1 year | 1,801.4 | | 2,537.6 |
| 3 years | 722.1 | | 2,537.6 |
| 5 years | 348.5 | | 2,537.6 |
| 10 years | 161.65 | | 2,537.6 |
Monthly variations
Annual variations
| 2026 | +12.95% | ||
| 2025 | +26.48% | ||
| 2024 | +88.43% | ||
| 2023 | +101.33% | ||
| 2022 | -19.75% | ||
| 2021 | +7.10% | ||
| 2020 | +42.03% | ||
| 2019 | -49.87% | ||
| 2018 | +16.53% | ||
| 2017 | -33.06% | ||
| 2016 | -3.63% | ||
| 2015 | +19.70% | ||
| 2014 | +44.27% | ||
| 2013 | +1.00% | ||
| 2012 | +80.05% | ||
| 2011 | -18.93% | ||
| 2010 | +31.27% | ||
| 2009 | -6.84% | ||
| 2008 | -50.32% | ||
| 2007 | +97.78% | ||
| 2006 | +92.22% | ||
| 2005 | +29.33% | ||
| 2004 | +238.85% | ||
| 2003 | +198.25% | ||
| 2002 | +26.86% | ||
| 2001 | -7.37% | ||
| 2000 | -62.36% |
- Stock Market
- Stocks
- GLENMARK Stock
- Quotes Glenmark Pharmaceuticals Limited
Select your edition
All financial news and data tailored to specific country editions
